• Pharmacokinetics of CSBTA in MASH: Transporter and Enzyme Mo

  2026-06-05

  This study systematically investigates how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids (CSBTA) in a mouse model. By dissecting the roles of hepatic enzymes and membrane transporters, the work offers essential insights for optimizing CSBTA-based regimens and understanding PK variability in chronic liver disease.

• Angiotensin II in Vascular Angiogenesis: Mechanistic and Tra

  2026-06-05

  Explore how Angiotensin II orchestrates vascular angiogenesis through LOX-1–dependent signaling, offering advanced context for hypertension and vascular remodeling research. This article delivers a unique, mechanism-focused perspective on Angiotensin II peptide applications.

• 2X Taq PCR Master Mix: Streamlining PCR for Genotyping & Clo

  2026-06-04

  The 2X Taq PCR Master Mix (with dye) revolutionizes PCR workflows by combining robust DNA amplification with direct gel loading, minimizing hands-on steps for genotyping and TA cloning. Its ready-to-use formulation and optimized enzyme activity empower molecular biologists to achieve reproducible results faster, with less error and greater confidence in downstream applications.

• 4-Hydroxytamoxifen: Protocol Guidance and Workflow QC

  2026-06-04

  4-Hydroxytamoxifen (SKU B6167) is a high-purity estrogen receptor modulator suited for DMSO-based protocols in breast cancer, prostate cancer, and cardiac myocyte calcium handling studies. It should not be used in workflows requiring aqueous or ethanol solubility, and strict storage conditions are essential for reproducibility.

• CCK-8 Regulates ANP Secretion via NOX4–PGC-1α–PPAR Axis in R

  2026-06-03

  This study uncovers a mechanistic link between cholecystokinin octapeptide (CCK-8) and atrial natriuretic peptide (ANP) secretion, mediated by NOX4–PGC-1α–PPARα/PPARγ signaling in isolated beating rat atria. The findings offer new insight into cardiac hormone regulation and oxidative stress signaling relevant to cardiovascular physiology and pathophysiology.

• TSPAN18 Stabilizes STIM1 to Drive Prostate Cancer Bone Metas

  2026-06-03

  Zhou et al. identify TSPAN18 as a key regulator of bone metastasis in prostate cancer by protecting STIM1 from TRIM32-mediated ubiquitination, stabilizing STIM1 protein, and promoting calcium influx. This mechanistic insight highlights TSPAN18 as a potential therapeutic target in advanced prostate cancer and provides a foundation for future translational strategies.

• High-Throughput BBB Model Enhances CNS Drug Screening Accura

  2026-06-02

  The reference study introduces a robust in vitro blood-brain barrier (BBB) model using LLC-PK1-MOCK/MDR1 cells combined with lysosomal trapping correction, enabling predictive, high-throughput assessment of CNS drug permeability. These innovations streamline early-phase CNS drug development by improving the translatability and mechanistic insight of BBB penetration assays.

• Anlotinib Hydrochloride Inhibits Tumor Angiogenesis via Mult

  2026-06-02

  This study demonstrates that Anlotinib hydrochloride potently inhibits angiogenesis by suppressing VEGFR2, PDGFRβ, and FGFR1 activation. Its superior efficacy in impairing endothelial cell migration and tube formation, compared to established TKIs, highlights its value as a research tool and potential therapeutic lead.

• FXR-KLF11 Axis Suppresses JAK2/STAT3 to Protect Against CI-A

  2026-06-01

  This study identifies the FXR-mediated transcriptional upregulation of KLF11 as a key protective mechanism against contrast-induced acute kidney injury (CI-AKI), acting via suppression of the JAK2/STAT3 signaling pathway. The findings provide mechanistic insight into renal inflammation and highlight the FXR-KLF11 axis as a potential target for prophylactic intervention in CI-AKI.

• G418 Sulfate (Geneticin): Precision Selection & Antiviral In

  2026-06-01

  G418 Sulfate (Geneticin) from APExBIO stands out as a dual-purpose powerhouse—delivering both high-fidelity selection in genetic engineering and robust antiviral activity, notably against Dengue virus serotype 2. This article details optimized experimental workflows, troubleshooting strategies, and key advances drawn from recent immunometabolism research to maximize your cell engineering and virology assays.

• Arachidonic Acid Supplementation Accelerates Humoral Immunit

  2026-05-31

  Dietary arachidonic acid (ARA) supplementation significantly enhances the speed and magnitude of vaccine-induced neutralizing antibody responses in mice and humans. This study provides mechanistic evidence that ARA acts as a potent nutritional adjuvant, opening new avenues for optimizing humoral immunity and vaccination protocols.

• (R,S)-Anatabine in Neurodegeneration Research: Applied Workf

  2026-05-30

  (R,S)-Anatabine enables targeted, mechanistically selective reduction of soluble Aβ peptides for translational Alzheimer’s disease research. This article demystifies experimental design, troubleshooting, and comparative advantages of Anatabine, empowering bench scientists to maximize impact in both in vitro and in vivo neurodegeneration models.

• Balsalazide Disodium: Optimized Protocols for IBD Research

  2026-05-29

  Balsalazide Disodium Dihydrate delivers precise, colon-targeted anti-inflammatory action for advanced ulcerative colitis models and immunology assays. Its high water solubility and unique prodrug mechanism enable robust radiolabeling, reproducible cytokine signaling studies, and translational animal workflows—outpacing traditional 5-ASA agents in both speed and specificity.

• Fucoidan: Translational Leverage for Oncology and Immunity

  2026-05-29

  Explore the mechanistic and strategic dimensions of Fucoidan—a sulfated α-L-fucan—in cancer research. This thought-leadership article connects apoptosis, immune modulation, and angiogenesis suppression with actionable translational guidance and an outlook on next-generation applications. Drawing on peer-reviewed findings and workflow integration, it positions APExBIO’s Fucoidan as a pivotal tool for innovative oncology and immunology platforms.

• Cyclopamine and Hedgehog Inhibition: Deep Mechanistic Insigh

  2026-05-28

  Explore how Cyclopamine, a potent Hedgehog signaling inhibitor, enables breakthrough research on cancer, teratogenicity, and developmental pathways. This article delivers a unique, in-depth analysis of Cyclopamine's molecular action and strategic applications.

16146 records 1/1077 page Next 12345 下5页 Last page